Intracellular localization of protein C inhibitor (PCI) and urinary plasminogen activator in renal tubular epithelial cells from humans and human PCI gene transgenic mice

被引:5
作者
Song, Zhenhu
Ma, Ning
Hayashi, Tatsuya
Gabazza, Esteban C.
Sugimura, Yoshiki
Suzuki, Koji [1 ]
机构
[1] Mie Univ, Grad Sch Med, Dept Mol Pathobiol, Tsu, Mie 5148507, Japan
[2] Mie Univ, Grad Sch Med, Dept Anat, Tsu, Mie 5148507, Japan
[3] Mie Univ, Grad Sch Med, Dept Urol, Tsu, Mie 5148507, Japan
基金
日本学术振兴会;
关键词
protein C inhibitor; urinary plasminogen activator; immunogold double labeling electron microscopy;
D O I
10.1007/s00418-007-0330-6
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Urinary plasminogen activator (uPA) is a serine protease that plays important roles in various extracellular proteolytic processes. In humans, protein C inhibitor (PCI) is known to regulate the activity of the serine proteases involved in blood coagulation, wound healing, and tumor metastasis, whereas PCI is not present in murine plasma or tissues other than the reproductive tissues. The large amount of uPA-PCI complexes found in human urine suggests that these complexes are formed in the kidneys. In the present study, we performed immunofluorescence double labeling and electron microscopic immunocytochemistry using renal tissues from humans and human PCI gene transgenic (PCI-TG) mice. In human renal tissues, PCI and uPA colocalized in the cytoplasm of renal proximal tubular epithelial cells (RPTECs), and juxtaposition of PCI and uPA immunoreactive particles was detected in the microvilli and lysosomes in the RPTECs. The intracellular distributions of PCI and uPA in the RPTECs from PCI-TG mice were similar to those observed in human RPTECs. These findings hint at the physiological roles of uPA and PCI in human kidneys, and also suggest that the PCI-TG mice will be useful for evaluating the roles of PCI in human physiological and pathological conditions.
引用
收藏
页码:293 / 300
页数:8
相关论文
共 47 条
[1]   Expression of plasminogen activators in preimplantation rat embryos developed in vivo and in vitro -: art. no. 7 [J].
Aflalo, ED ;
Sod-Moriah, UA ;
Potashnik, G ;
Har-Vardi, I .
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2005, 3 (1) :1-8
[2]  
Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO
[3]  
2-Z
[4]   Protein C inhibitor inhibits breast cancer cell growth, metastasis and angiogenesis independently of its protease inhibitory activity [J].
Asanuma, Kunihiro ;
Yoshikawa, Tomoaki ;
Hayashi, Tatsuya ;
Akita, Nobuyuki ;
Nakagawa, Norimi ;
Hamada, Yasuhiko ;
Nishioka, Junji ;
Kamada, Haruhiko ;
Gabazza, Esteban C. ;
Ido, Masaru ;
Uchida, Atsumasa ;
Suzuki, Koji .
INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (05) :955-965
[5]   UROKINASE-PLASMINOGEN ACTIVATOR IS SYNTHESIZED IN-VITRO BY HUMAN GLOMERULAR EPITHELIAL-CELLS BUT NOT BY MESANGIAL CELLS [J].
BROWN, PAJ ;
WILSON, HM ;
REID, FJ ;
BOOTH, NA ;
SIMPSON, JG ;
MORRISON, L ;
POWER, DA ;
HAITES, NE .
KIDNEY INTERNATIONAL, 1994, 45 (01) :43-47
[6]   Expression of protein C inhibitor (PCI) in benign and malignant prostatic tissues [J].
Cao, Y ;
Becker, C ;
Lundwall, Å ;
Christensson, A ;
Gadaleanu, V ;
Lilja, H ;
Bjartell, A .
PROSTATE, 2003, 57 (03) :196-204
[7]   Urokinase signal transduction and its role in cell migration [J].
Carlin, SM ;
Resink, TJ ;
Tamm, M ;
Roth, M .
FASEB JOURNAL, 2005, 19 (02) :195-202
[8]   Molecular mechanisms of fibrinolysis [J].
Cesarman-Maus, G ;
Hajjar, KA .
BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 (03) :307-321
[9]  
CONESE M, 1995, BIOL CHEM H-S, V376, P143
[10]   The urokinase plasminogen activator system: Role in malignancy [J].
Duffy, MJ .
CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (01) :39-49